IP Library Granted Patent US 9,511,223
Granted Patent B2
US 9,511,223 · App. 14/619,898 · Granted Dec 6, 2016

Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,511,223
App. No.
14/619,898
Granted
Dec 6, 2016
Kind
B2
Abstract

The present disclosure relates to methods, devices, and systems used for the treatment of mood, anxiety, cognitive, and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.

Claims (22)

1. A method for treating a neuropsychiatric disorder by trigeminal nerve stimulation, comprising:

implanting a subcutaneous electrode assembly below an epidermis and above a pericranium of a patient so that a first electrode contact is in contact with an ophthalmic nerve on one side of the patient's forehead and so that a second electrode contact is in contact with an ophthalmic nerve on an opposing side of the patient's forehead; and

applying electrical signals to the electrode assembly so that current flows at the first electrode contact and the second electrode contact at specified operational parameters to treat the neuropsychiatric disorder, wherein the electrical signals are applied to minimize current penetration into a brain of the patient such that a charge density at the brain's surface does not exceed 20 μC/cm 2 .

2. The method of claim 1 , wherein the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a current of 0.1 to 3 milliamperes (mA), and at a pulse duration of less than or equal to 500 microseconds.

3. The method of claim 1 , wherein the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a pulse duration between approximately 50 and 500 microseconds, at an output current density of not greater than approximately 25 mA/cm 2 , and a charge density of not greater than approximately 10 microCoulomb/cm 2 at a cerebral cortex of the patient.

4. The method of claim 1 , wherein the neuropsychiatric disorder is a mood disorder, a cognitive disorder, a behavioral disorder, an anxiety disorder, or a combination thereof.

5. A method for treating a neuropsychiatric disorder by trigeminal nerve stimulation, comprising:

implanting a subcutaneous electrode assembly below an epidermis and above a pericranium of a patient so that at least one first electrode contact is at an ophthalmic nerve on one side of the patient's forehead; and

applying electrical signals to the electrode assembly at specified operational parameters to treat the neuropsychiatric disorder, wherein the electrical signals are applied to minimize current penetration into a brain for the patient such that a charge density at the brain's surface does not exceed 20 μC/cm 2 .

6. The method of claim 5 , wherein the implanting of the subcutaneous electrode assembly is so that at least one second electrode contact is at an ophthalmic nerve on an opposing side of the patient's forehead.

7. The method of claim 5 , wherein the at least one first electrode contact comprises a first plurality of electrode contacts, and wherein the at least one second electrode contact comprises a second plurality of electrode contacts.

8. The method of claim 5 , wherein the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a current of 0.1 to 3 milliamperes (mA), and at a pulse duration of less than or equal to 500 microseconds.

9. The method of claim 5 , wherein the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a pulse duration between approximately 50 and 500 microseconds, at an output current density of not greater than approximately 25 mA/cm 2 , and a charge density of not greater than approximately 10 microCoulomb/cm 2 at a cerebral cortex of the patient.

10. The method of claim 5 , wherein the neuropsychiatric disorder is a mood disorder, a cognitive disorder, a behavioral disorder, an anxiety disorder, or a combination thereof.

11. A method for treating a neuropsychiatric disorder by trigeminal nerve stimulation, comprising:

implanting a subcutaneous electrode assembly below an epidermis and above a pericranium of a patient so that at least one first electrode contact is at a supraorbital nerve on one side of the patient's forehead and at least one second electrode contact is at a supratrochlear nerve on the one side of the patient's forehead; and

applying electrical signals to the electrode assembly at specified operational parameters to treat the neuropsychiatric disorder, wherein the electrical signals are applied to minimize current penetration into a brain for the patient such that a charge density at the brain's surface does not exceed 20 μC/cm 2 .

12. The method of claim 11 , wherein the implanting of the subcutaneous electrode assembly is so that at least one third electrode contact is at a supraorbital nerve on an opposing side of the patient's forehead and at least one fourth contact is at a supratrochlear nerve on the opposing side of the patient's forehead.

13. The method of claim 11 , wherein the at least one first electrode contact comprises a first plurality of electrode contacts, wherein the at least one second electrode contact comprises a second plurality of electrode contacts, wherein the at least one third electrode contact comprises a third plurality of electrode contacts, and wherein the at least one fourth electrode contact comprises a fourth plurality of electrode contacts.

14. The method of claim 11 , wherein the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a current of 0.1 to 3 milliamperes (mA), and at a pulse duration of less than or equal to 500 microseconds.

15. The method of claim 11 , wherein the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a pulse duration between approximately 50 and 500 microseconds, at an output current density of not greater than approximately 25 mA/cm 2 , and a charge density of not greater than approximately 10 microCoulomb/cm 2 at a cerebral cortex of the patient.

16. The method of claim 11 , wherein the neuropsychiatric disorder is a mood disorder, a cognitive disorder, a behavioral disorder, an anxiety disorder, or a combination thereof.

Assignments (3)
LIEN Recorded Mar 20, 2019
From: NEUROSIGMA, INC.
To: DE SALLES, ANTONIO A.F.; GORGULHO, ALESSANDRA
Reel/Frame 048649/0380 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2015
From: DEGIORGIO, CHRISTOPHER M.; COOK, IAN A.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 034942/0047 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2015
From: EKCHIAN, LEON
To: NEUROSIGMA, INC.
Reel/Frame 034942/0112 →